{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:37:55Z","timestamp":1793263075471,"version":"4.5.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Iron deficiency (ID) is the most common nutritional deficiency, with little research on its prevalence and long-term outcomes in the general population and those with heart failure (HF). Both the relationships between dietary iron and ID, as well as dietary folate and ID, are understudied.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We used data from the National Health and Nutrition Examination Survey from 1999 to 2002 to investigate the prevalence, prognosis, and relationship between dietary and ID defined by different criteria in the general population (<jats:italic>n<\/jats:italic>\u2009=\u20096,660) and those with HF (<jats:italic>n<\/jats:italic>\u2009=\u2009182).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There was no significant difference in the prevalence of ID between HF patients and the general population after propensity score matching. Transferrin saturation (TSAT) &amp;lt;20% was associated with higher 5-year all-cause mortality (HR: 3.49, CI: 1.40\u20138.72, <jats:italic>P<\/jats:italic>\u2009=\u20090.007), while ferritin &amp;lt;30\u2005ng\/ml was associated with higher 10-year (HR: 2.70, CI: 1.10\u20136.67, <jats:italic>P<\/jats:italic>\u2009=\u20090.031) and 15-year all-cause mortality (HR: 2.64, CI: 1.40\u20135.00, <jats:italic>P<\/jats:italic>\u2009=\u20090.003) in HF patients. Higher dietary total folate but dietary iron reduced the risk of ID (defined as ferritin &amp;lt;100\u2005ng\/ml) in HF patients (OR: 0.80; 95% CI: 0.65\u20131.00; <jats:italic>P<\/jats:italic>\u2009=\u20090.047).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The prevalence of ID was identical in HF and non-HF individuals. Ferritin &amp;lt;30\u2005ng\/ml was associated with long-term outcomes whereas TSAT &amp;lt;20% was associated with short-term prognosis in both the general population and HF patients. A diet rich in folate might have the potential for prevention and treatment of ID in HF patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2024.1342686","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T04:53:03Z","timestamp":1710737583000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Iron deficiency: prevalence, mortality risk, and dietary relationships in general and heart failure populations"],"prefix":"10.3389","volume":"11","author":[{"given":"Hui","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingquan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: an international pooled analysis","volume":"165","author":"Klip","year":"2013","journal-title":"Am Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.cardfail.2011.08.003","article-title":"Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure","volume":"17","author":"Jankowska","year":"2011","journal-title":"J Card Fail"},{"key":"B3","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/ejhf.139","article-title":"High prevalence of iron deficiency in patients with acute decompensated heart failure","volume":"16","author":"Cohen-Solal","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: an ominous sign in patients with systolic chronic heart failure","volume":"31","author":"Jankowska","year":"2010","journal-title":"Eur Heart J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1161\/circheartfailure.111.960906","article-title":"Iron deficiency in community-dwelling US adults with self-reported heart failure in the national health and nutrition examination survey III: prevalence and associations with anemia and inflammation","volume":"4","author":"Parikh","year":"2011","journal-title":"Circ Heart Fail"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1002\/ehf2.13589","article-title":"Association of iron deficiency with incident cardiovascular diseases and mortality in the general population","volume":"8","author":"Schrage","year":"2021","journal-title":"ESC Heart Fail"},{"key":"B7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jacc.2021.11.039","article-title":"Criteria for iron deficiency in patients with heart failure","volume":"79","author":"Masini","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/s0140-6736(22)02083-9","article-title":"Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial","volume":"400","author":"Kalra","year":"2022","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"B10","volume-title":"WHO Guideline on Use of Ferritin Concentrations to Assess Iron Status in Individuals and Populations","year":"2020"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e004519","DOI":"10.1161\/circheartfailure.117.004519","article-title":"Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients","volume":"11","author":"Grote Beverborg","year":"2018","journal-title":"Circ Heart Fail"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ejhf.2333","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). with the special contribution of the heart failure association (HFA) of the ESC","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"B13","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines and the heart failure society of America","volume":"70","author":"Yancy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/bjh.16409","article-title":"The prevalence and associated mortality of non-anaemic iron deficiency in older adults: a 14 years observational cohort study","volume":"189","author":"Philip","year":"2020","journal-title":"Br J Haematol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.1002\/ehf2.13617","article-title":"Impact of change in iron status over time on clinical outcomes in heart failure according to ejection fraction phenotype","volume":"8","author":"Fitzsimons","year":"2021","journal-title":"ESC Heart Fail"},{"key":"B16","doi-asserted-by":"publisher","first-page":"5144","DOI":"10.3390\/nu14235144","article-title":"Dietary iron intake and biomarkers of iron Status in slovenian population: results of SI.menu\/nutrihealth study","volume":"14","author":"Lavri\u0161a","year":"2022","journal-title":"Nutrients"},{"key":"B17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/nu10010081","article-title":"Association between haem and non-haem iron intake and Serum ferritin in healthy young women","volume":"10","author":"Young","year":"2018","journal-title":"Nutrients"},{"key":"B18","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3390\/nu14030452","article-title":"Efficacy and safety of ferrous bisglycinate and folinic acid in the control of iron deficiency in pregnant women: a randomized, controlled trial","volume":"14","author":"Bumrungpert","year":"2022","journal-title":"Nutrients"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/j.1471-0528.2002.01378.x","article-title":"Iron plus folate is more effective than iron alone in the treatment of iron deficiency anaemia in pregnancy: a randomised, double blind clinical trial","volume":"109","author":"Juarez-Vazquez","year":"2002","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"B20","article-title":"NHANES Questionnaires, Datasets, and Related Documentation","year":""},{"key":"B21","article-title":"NCHS Ethics Review Board (ERB) Approval","year":""},{"key":"B22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"B23","article-title":"2019 Public-Use Linked Mortality Files","year":""},{"key":"B24","doi-asserted-by":"publisher","first-page":"zvad105","DOI":"10.1093\/eurjcn\/zvad105","article-title":"Sex differences in the nutritional status and its association with long-term prognosis in patients with heart failure with reduced ejection fraction: a prospective cohort study","author":"Ka\u0142u\u017cna-Oleksy","year":"2024","journal-title":"Eur J Cardiovasc Nurs"},{"key":"B25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jchf.2018.07.015","article-title":"Iron deficiency in heart failure: an overview","volume":"7","author":"von Haehling","year":"2019","journal-title":"JACC Heart Fail"},{"key":"B26","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cardfail.2020.03.004","article-title":"Increased iron absorption in patients with chronic heart failure and iron deficiency","volume":"26","author":"Cabrera","year":"2020","journal-title":"J Card Fail"},{"key":"B27","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/ejhf.2251","article-title":"Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure","volume":"24","author":"Graham","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"B28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.healun.2021.01.1390","article-title":"Intravenous iron supplement for iron deficiency in cardiac transplant recipients (IronIC): a randomized clinical trial","volume":"40","author":"Brautaset Englund","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1080\/10408398.2013.866543","article-title":"Iron bioavailability in iron-fortified cereal foods: the contribution of in vitro studies","volume":"57","author":"Diego Quintaes","year":"2017","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial","volume":"317","author":"Lewis","year":"2017","journal-title":"JAMA"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1342686\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T04:53:05Z","timestamp":1710737585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1342686\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,18]]},"references-count":30,"alternative-id":["10.3389\/fcvm.2024.1342686"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1342686","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,18]]},"article-number":"1342686"}}